Diagnostic anti-influenza h5 and h7 subtypes antibodies pairs and antigens for animal health (animal infectious disease ) testing in ELISA test,competitive ELISA test, blocking ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), and immunonephelometry
Catalog Number: GMP-AD-Avian-8
Definition of the disease: Avian influenza A viruses do not normally infect people, but sporadic infections in people have occurred with some avian influenza A viruses. Illnesses in humans from avian influenza A virus infections have ranged in severity from asymptomatic to mild to severe and fatal disease. Human infections with avian influenza A viruses have most often occurred after contact with infected birds or their secretions or excretions. Three subtypes of avian influenza A viruses are known to infect people (H5, H7 and H9 viruses). Among these, Asian lineage H5N1 and H7N9 have caused the majority of infections in people.
Genemedi produces core animal health diagnostic ingredients-validated antibodies pairs Mouse anti-influenza h5 and h7 subtypes monoclonal antibodies and influenza h5 and h7 subtypes antigens for rapid test kit of animal infectious disease with influenza h5 and h7 subtypes to evaluate the animal health of Avian (Bird).
The paired antibodies are both monoclonal antibody(mab).
All the antibodies and antiges of animal disease test are suitable for in functional ELISA, and other immunoassays in dignostics.The antibody can act as a capture antibody and detection antibody. Antigens are validated as positive control materials.
Order information
Catalog No. (1~4, 4 antibodies in pairs) |
Size | Price(In USD) | Qty (Quantity) | Sum(In USD) |
---|---|---|---|---|
GMP-AD-Avian-8Ab-1 | Size:1mg | 3090 | ||
GMP-AD-Avian-8Ab-1 | Size:10mg | 21935 | ||
GMP-AD-Avian-8Ab-1 | Size:100mg | 148000 | ||
GMP-AD-Avian-8Ab-2 | Size:1mg | 3090 | ||
GMP-AD-Avian-8Ab-2 | Size:10mg | 21935 | ||
GMP-AD-Avian-8Ab-2 | Size:100mg | 148000 | ||
GMP-AD-Avian-8Ab-3 | Size:1mg | 3090 | ||
GMP-AD-Avian-8Ab-3 | Size:10mg | 21935 | ||
GMP-AD-Avian-8Ab-3 | Size:100mg | 148000 | ||
GMP-AD-Avian-8Ab-4 | Size:1mg | 3090 | ||
GMP-AD-Avian-8Ab-4 | Size:10mg | 21935 | ||
GMP-AD-Avian-8Ab-4 | Size:100mg | 148000 | ||
GMP-AD-Avian-8Ag-1 | Size:1mg | 3090 | ||
GMP-AD-Avian-8Ag-1 | Size:10mg | 21935 | ||
GMP-AD-Avian-8Ag-1 | Size:100mg | 148000 | ||
GMP-AD-Avian-8Ag-2 | Size:1mg | 3090 | ||
GMP-AD-Avian-8Ag-2 | Size:10mg | 21935 | ||
GMP-AD-Avian-8Ag-2 | Size:100mg | 148000 | ||
Shipping Cost: | 760.00 | |||
Total: | ||||
Description
GMP-AD-Avian-8Ab, GMP-AD-Avian-8Ag
Cat No. | GMP-AD-Avian-8Ab |
Antigens | influenza h5 and h7 subtypes |
Antibody | Mouse anti-influenza h5 and h7 subtypes monoclonal antibodies |
Resource (expression host) | hybridoma |
Specics/Isotypes | Mouse IgG |
Bioactivity validation | Antibody Binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays in influenza h5 and h7 subtypes level test and Avian (Bird)-diagnositcs. |
Antigen description | Infectious bursal disease (IBD), also known as Gumboro disease, infectious bursitis and infectious avian nephrosis, is a highly contagious disease of young chickens and turkeys caused by infectious bursal disease virus (IBDV), characterized by immunosuppression and mortality generally at 3 to 6 weeks of age. The disease was first discovered in Gumboro, Delaware in 1962. It is economically important to the poultry industry worldwide due to increased susceptibility to other diseases and negative interference with effective vaccination. In recent years, very virulent strains of IBDV (vvIBDV), causing severe mortality in chicken, have emerged in Europe, Latin America, South-East Asia, Africa and the Middle East. Infection is via the oro-fecal route, with affected bird excreting high levels of the virus for approximately 2 weeks after infection. The disease is easily spread from infected chickens to healthy chickens through food, water, and physical contact. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in Sandwich ELISA, Lateral flow immunoassay (LFIA), and other immunoassays; |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. | GMP-AD-Avian-8Ag |
Antigens | influenza h5 and h7 subtypes |
Resource (expression host) | E.coli |
Specics/Isotypes | influenza h5 and h7 subtypes |
Bioactivity validation | Antibody Binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays in influenza h5 and h7 subtypes level test and Avian (Bird)-diagnositcs. |
Tag | His |
Antigen description | Infectious bursal disease (IBD), also known as Gumboro disease, infectious bursitis and infectious avian nephrosis, is a highly contagious disease of young chickens and turkeys caused by infectious bursal disease virus (IBDV), characterized by immunosuppression and mortality generally at 3 to 6 weeks of age. The disease was first discovered in Gumboro, Delaware in 1962. It is economically important to the poultry industry worldwide due to increased susceptibility to other diseases and negative interference with effective vaccination. In recent years, very virulent strains of IBDV (vvIBDV), causing severe mortality in chicken, have emerged in Europe, Latin America, South-East Asia, Africa and the Middle East. Infection is via the oro-fecal route, with affected bird excreting high levels of the virus for approximately 2 weeks after infection. The disease is easily spread from infected chickens to healthy chickens through food, water, and physical contact. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in Sandwich ELISA, Lateral flow immunoassay (LFIA), and other immunoassays; |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -87℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
- GENEMEDI
- Email: [email protected] [email protected]
- Telephone: +86-21-50478399 Fax: 86-21-50478399
- Privacy Policy
- TECHNICAL SUPPORT
- Product FAQs
- Technical manuals
- Publications
- Email: [email protected]
![](/images/gototop.png)
![](https://www.genemedi.net/images/ad.png)